Wolverine Asset Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Wolverine Asset Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-122,921	Closed	-$40.6K	–	1845
2025 Q4	$40.6K	Buy	122,921 +86,763	+240%	+$19K	﹤0.01%	1296
2025 Q3	$7.31K	Buy	+36,158	New	+$7.59K	﹤0.01%	1399
2025 Q1	–	Sell	-458	Closed	-$105	–	1712
2024 Q4	$105	Sell	458 -27,989	-98%	-$3.62K	﹤0.01%	1591
2024 Q3	$2.78K	Buy	28,447 +9,322	+49%	+$1.63K	﹤0.01%	1464
2024 Q2	$3.06K	Buy	+19,125	New	+$3.91K	﹤0.01%	1460
2024 Q1	–	Sell	-3,963	Closed	-$237	–	1836
2023 Q4	$237	Buy	+3,963	New	+$224	﹤0.01%	1695
2021 Q2	–	Sell	-1,749	Closed	-$4K	–	2338
2021 Q1	$4K	Buy	+1,749	New	+$5.06K	﹤0.01%	1939

Wolverine Asset Management's NUVB.WS Position: Q1 2026 in Review

Wolverine Asset Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 122,921 shares — an estimated $40.6K sold.

Wolverine Asset Management first reported a position in NUVB.WS in Q1 2021 and held it in 7 quarters. The position peaked at $40.6K in Q4 2025. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

Wolverine Asset Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
Wolverine Asset Management sold 122,921 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $40.6K.
Wolverine Asset Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 7 quarters.
Wolverine Asset Management's Nuvation Bio Inc Warrants position peaked at $40.6K in Q4 2025.
0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.